The Patent Finder

Onyx Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Onyx Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Onyx Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,809,526Synthesis of cyclopentaquinazolines
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,458,188Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (G) quinazoline trisodium salt
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 6,500,653Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins
Term ended
Term ended Aug 9, 2019 · USPTO record
Term endedTerm ended Aug 9, 2019USPTO record
US 6,428,960Selection method for producing recombinant baculovirus
Term ended
Term ended Mar 4, 2019 · USPTO record
Term endedTerm ended Mar 4, 2019USPTO record
US 6,017,763G-beta-gamma regulated phosphatidylinositol-3' kinase
Term ended
Term ended Jan 4, 2019 · USPTO record
Term endedTerm ended Jan 4, 2019USPTO record
US 7,785,887Adenovirus E1B-55K Single Amino Acid Mutants and Methods of Use
Lapsed on the fee record
Ended Aug 31, 2018 · Medium confidence
Lapsed on the fee recordEnded Aug 31, 2018Medium confidence
US 6,048,706Human PAK65
Term ended
Term ended Jul 1, 2018 · USPTO record
Term endedTerm ended Jul 1, 2018USPTO record
US 6,187,799Inhibition of raf kinase activity using aryl ureas
Formerly held
Term ended
Term ended May 22, 2018 · USPTO record
Term endedTerm ended May 22, 2018USPTO record
US 6,340,575Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
Term ended
Term ended May 15, 2018 · USPTO record
Term endedTerm ended May 15, 2018USPTO record
US 6,133,419Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
Term ended
Term ended Oct 1, 2017 · USPTO record
Term endedTerm ended Oct 1, 2017USPTO record
10 of 60 patents shown.
Pro members see all 60.
Pro members: see all 60 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited